tiprankstipranks
BioNTech SE (BNTX)
NASDAQ:BNTX
US Market

BioNTech SE (BNTX) Financial Statements

Compare
4,493 Followers

BioNTech SE Financial Overview

BioNTech SE's market cap is currently $22.89B. The company's EPS TTM is $-3.018; its P/E ratio is ―; BioNTech SE is scheduled to report earnings on March 10, 2025, and the estimated EPS forecast is $-2.16. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue€ 2.75B€ 3.82B€ 17.31B€ 18.98B€ 482.32M
Gross Profit€ 2.21B€ 3.22B€ 12.78B€ 15.12B€ -222.04M
Operating Income€ -1.31B€ 690.40M€ 12.64B€ 15.28B€ -82.42M
EBITDA€ -367.10M€ 1.09B€ 12.43B€ 15.00B€ -105.10M
Net Income€ -665.30M€ 930.30M€ 9.43B€ 10.29B€ 15.20M
Balance Sheet
Cash & Short-Term Investments€ 16.78B€ 16.55B€ 14.06B€ 2.07B€ 1.35B
Total Assets€ 22.53B€ 23.01B€ 23.28B€ 15.83B€ 2.32B
Total Debt€ 254.20M€ 219.10M€ 212.20M€ 301.50M€ 240.19M
Net Debt€ -9.51B€ -11.44B€ -13.66B€ -1.39B€ -970.02M
Total Liabilities€ 3.12B€ 2.76B€ 3.22B€ 3.94B€ 946.77M
Stockholders' Equity€ 19.41B€ 20.25B€ 20.06B€ 11.89B€ 1.37B
Cash Flow
Free Cash Flow€ -244.60M€ 4.67B€ 13.21B€ 735.70M€ -98.92M
Operating Cash Flow€ 207.70M€ 5.37B€ 13.58B€ 889.70M€ -13.47M
Investing Cash Flow€ -2.08B€ -6.95B€ -35.30M€ -566.10M€ -144.85M
Financing Cash Flow€ -45.90M€ -778.60M€ -1.42B€ 94.20M€ 894.73M
Currency in EUR

BioNTech SE Earnings and Revenue History

BioNTech SE Debt to Assets

BioNTech SE Cash Flow

BioNTech SE Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis